Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01748214 · ClinicalTrials.gov registry record
Premature Infant Exposure to Noise Generated by Respiratory Support
A clinical trial of Premature Birth of Newborn, sponsored by University of Virginia.
- Completed
- Registry status
- 28
- Enrollment target
- 1
- Study location
NCT01748214: Completed study of Premature Birth of Newborn, sponsored by University of Virginia.
NCT01748214 is a study of Premature Birth of Newborn that has completed, run by University of Virginia. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01748214, a study of Premature Birth of Newborn, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
Infants in neonatal intensive care units are increasing exposed to non-invasive ventilatory support modes (nasal continuous positive airway pressure - NCPAP and high flow nasal cannula: \>1 L/min flow - HFNC). While there have been small descriptive studies of noise exposure in infants on NCPAP, there have been no comparative trials done comparing noise exposure in infants undergoing both NCPAP and HFNC. Objective: Using a cross-over model determine noise exposure levels in infants exposed to similar levels of respiratory support provided by NCPAP and HFNC.
Primary Outcome
Noise levels will be measured during a set time while infants are on Nasal CPAP and Nasal High flow cannula as standard of care
Conditions Studied
Study Locations (1)
Virginia
- University of Virginia Health System - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-11 |
What the finished NCT01748214 record still lists
NCT01748214 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 1 condition, with Premature Birth of Newborn appearing as the primary indexed condition, and to 0 interventions.
NCT01748214 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT01748214 about?
NCT01748214 is a clinical study titled "Premature Infant Exposure to Noise Generated by Respiratory Support". Infants in neonatal intensive care units are increasing exposed to non-invasive ventilatory support modes (nasal continuous positive airway pressure - NCPAP and high flow nasal cannula: \>1 L/min flow - HFNC). While there have been small descriptive studies of noise exposure in infants on NCPAP, the...
What is the current status of trial NCT01748214?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2008-11. Estimated completion is 2010-11.
What conditions does trial NCT01748214 study?
This clinical trial studies the following conditions: Premature Birth of Newborn.
Who is sponsoring clinical trial NCT01748214?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01748214 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Birth of Newborn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia